Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty
- 30 April 1994
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 23 (5) , 1061-1065
- https://doi.org/10.1016/0735-1097(94)90590-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparinCatheterization and Cardiovascular Diagnosis, 1992
- Validation of a bedside method of activated partial thromboplastin time measurement with clinical range guidelinesThe American Journal of Cardiology, 1991
- Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.Heart, 1990
- Adequate heparinization during PTCA: Assessment using activated clotting timesCatheterization and Cardiovascular Diagnosis, 1989
- Adequate Anticoagulation During Cardiopulmonary Bypass Determined by Activated Clotting Time and the Appearance of Fibrin MonomerThe Annals of Thoracic Surgery, 1978
- Control of Heparinization by Activated Clotting Time During Bypass with Improved Postoperative HemostasisThe Annals of Thoracic Surgery, 1977
- Use of the Activated Coagulation Time in Intraoperative Heparin Reversal for Cardiopulmonary OperationsThe Annals of Thoracic Surgery, 1975
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975
- A Simple Method of Heparin Management During Prolonged Extracorporeal CirculationThe Annals of Thoracic Surgery, 1974